Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.4950 (-7.28%) ($9.4950 - $9.4950) on Mon. Apr. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.94% (three month average) | RSI | 25 | Latest Price | $9.4950(-7.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.1% a day on average for past five trading days. | Weekly Trend | BCRX declines -3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(40%) IWO(36%) ARKG(34%) ARKK(34%) | Factors Impacting BCRX price | BCRX will decline at least -3.47% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-2%) IGOV(1%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.47% (StdDev 6.94%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.95 | 5 Day Moving Average | $10.12(-6.18%) | 10 Day Moving Average | $10.05(-5.52%) | 20 Day Moving Average | $10.95(-13.29%) | To recent high | -30.3% | To recent low | 18.3% | Market Cap | $1.675b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |